LRRK2 Kinase Inhibition as a Therapeutic Strategy for Parkinson's Disease, Where Do We Stand?

This is a publication. If there is no link to the publication on this page, you can try the pre-formated search via the search engines listed on this page.

Authors: Jean-Marc Taymans, Elisa Greggio

Journal title: Current Neuropharmacology

Journal number: 14/3

Journal publisher: Bentham Science Publishers

Published year: 2016

Published pages: 214-225

DOI identifier: 10.2174/1570159X13666151030102847

ISSN: 1570-159X